Dr. Reddy's Laboratories Limited (BOM:500124)
1,195.35
+38.95 (3.37%)
At close: May 12, 2025
Dr. Reddy's Laboratories Revenue
In the fiscal year ending March 31, 2025, Dr. Reddy's Laboratories had annual revenue of 325.54B INR with 16.61% growth. Dr. Reddy's Laboratories had revenue of 85.06B in the quarter ending March 31, 2025, with 20.09% growth.
Revenue
325.54B
Revenue Growth
+16.61%
P/S Ratio
3.06
Revenue / Employee
12.04M
Employees
27,048
Market Cap
995.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 325.54B | 46.37B | 16.61% |
Mar 31, 2024 | 279.16B | 33.29B | 13.54% |
Mar 31, 2023 | 245.88B | 31.49B | 14.69% |
Mar 31, 2022 | 214.39B | 24.67B | 13.00% |
Mar 31, 2021 | 189.72B | 15.12B | 8.66% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,646.93B |
HDFC Bank | 2,728.47B |
Tata Consultancy Services | 2,553.24B |
Bharti Airtel | 1,627.08B |
ICICI Bank | 2,006.54B |
State Bank of India | 3,429.39B |
Infosys | 1,647.16B |
Hindustan Unilever | 631.21B |
Dr. Reddy's Laboratories News
- 2 days ago - Dr. Reddy's Laboratories Limited (RDY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Dr Reddy’s Q4 PAT up 22% - The Times of India
- 2 days ago - Dr. Reddy's Q4 & Full Year FY25 Financial Results - Business Wire
- 3 days ago - Dr Reddy’s Q4 net profit rises 21% to Rs 1,587 crore on strong global sales - The Times of India
- 3 days ago - Earnings calendar for May 9: ABB, Dr Reddy’s, Bank of India, Manappuram, Thermax among key firms to report Q4 results - Business Upturn
- 3 days ago - Dr. Reddy's Q4 Earnings Preview - Seeking Alpha
- 16 days ago - Dr Reddys eyes global GLP-1 market with generic drug rollout on patent expiry - The Times of India
- 18 days ago - Nifty 50 top gainers today, April 24: IndusInd Bank, UltraTech Cement, Grasim Industries, Dr. Reddy’s and more - Business Upturn